Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

GLP-1 drugs linked to reduced risk of epilepsy

Written by | 14 Dec 2025

A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy. The findings appeared… read more.

UCB announces 21 data presentations spanning clinical research and real-world insights at AES 2025

Written by | 5 Dec 2025

UCB, a global biopharmaceutical company, today announced it will present 21 abstracts at the American Epilepsy Society (AES) Annual Meeting (December 5-9, 2025). Data include primary efficacy and… read more.

Xenon to present long-term Azetukalner results and lead patient-provider symposium at AES 2025

Written by | 5 Dec 2025

Xenon Pharmaceuticals Inc, a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, announced multiple presentations at the upcoming American… read more.

Use of head CT scans in ERs more than doubles over 15 years

Written by | 29 Nov 2025

A new study shows large increases in the use of computed tomography (CT) scans of the head in emergency departments across the United States from 2007 to 2022…. read more.

Lundbeck files for marketing authorization across key Asian markets for Vyepti (eptinezumab) for the preventive treatment of migraine

Written by | 21 Nov 2025

Lundbeck announced the  acceptance of its new drug application (NDA) for Vyepti  (eptinezumab) by the Ministry of Health, Labor and Welfare (MHLW) in Japan. The submission reflects the… read more.

Concussions linked to increased risk of a serious traffic crash

Written by | 19 Nov 2025

Adults diagnosed with a concussion may be at about 50 per cent higher risk of a subsequent traffic crash, finds a new study from researchers at ICES and Sunnybrook Research Institute. Concussions… read more.

New study demonstrates accuracy of two Quest AD-Detect tests for Alzheimer’s disease diagnosis – Quest Diagnostics

Written by | 8 Nov 2025

Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer’s disease pathology in symptomatic patients, supporting diagnosis, according to a new study in Neurology Clinical Practice,… read more.

Alexion to highlight advances across its rare neurology portfolio at AANEM and MGFA 2025

Written by | 31 Oct 2025

Alexion, AstraZeneca Rare Disease, will deliver 18 presentations, including four oral presentations, from its leading rare neurology portfolio at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)… read more.

New clinical trial to advance seizure monitoring and improve epilepsy diagnosis

Written by | 28 Oct 2025

A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and… read more.

Oral health is a major driver of ischemic stroke risk

Written by | 23 Oct 2025

People with gum disease plus cavities have a significantly increased risk of suffering an ischemic stroke compared to those with a healthy mouth, researchers report. The findings were… read more.

Groundbreaking study published in JAMA Neurology demonstrates effectiveness of BrainSense Adaptive deep brain stimulation for people with Parkinson’s – Medtronic

Written by | 14 Oct 2025

Medtronic announced the results from the Medtronic Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial now published in the distinguished Journal of the American Medical… read more.

Traumatic brain injury linked to dementia onset in seniors

Written by | 11 Oct 2025

Researchers report that traumatic brain injuries (TBI) in older adults are associated with new cases of dementia, use of home care services, and admission to long-term care. The… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.